To date, there is no evidence of hepatotoxicity, nephrotoxicity, or cardiac damage in any animal trialseven when administered in extremely high doses
Storage Instructions Store this product in a cool, dry place, out of reach of children
However, currently the use of GLP-1 RAs is not recommended as treatment of MASLD.(3) The American Diabetes Association 2025 guidelines similarly state GLP-1 RAs are recommended in adults with diabetes, obesity, and MASLD in combination with diet and exercise for weight loss
Additional investigations have evaluated PT-141 within broader studies of neuroendocrinology, reproductive biology, behavioral physiology, and autonomic nervous system regulation
As the number of adults diagnosed with diabetes rises, so does the demand for medication, driving the global market for Glucagon-like Peptide 1